ALE1 clinical trials

A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify Suitable Doses of ALE1

This study is looking into a new medicine called ALE1 for a rare bone condition called Hypophosphatasia (HPP). It will first check if ALE1 is safe in healthy adults, then see how it works in adults with HPP. The aim is to find suitable doses.